TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy

Grant

Awarded By

Total Award Amount

  • 51730.00

    • Direct Costs

  • 41057.00

    • Sponsor Award Id

  • 082

    • Contributor

  • Suzanne Oparil   Principal Investigator